HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Colony-promoting activity in mice kidneys with phenylhydrazine hemolytic anemia.

Abstract
Aqueous anemic mice kidney extracts (MKE) were assessed colony-promoting activity (CPA) of hematopoietic progenitor cells in serum-free cultures stimulated by interleukin-3 and erythropoietin (Epo). Mice with hemolytic anemia followed by phenylhydorazine (PHZ) injection for 3 days showed a decrease in the hematocrit (25.4%) and an increase in serum Epo by 14-fold of the control on day 3 after the treatment. At 3 days, the total number of hematopoietic progenitor cells in the bone marrow of PHZ mice decreased by 67% of the control, while these cells in the spleen increased to 22-fold of the control on day 3 and 55-fold on day 6. A significant increase in CPA was observed in MKE prepared from PHZ mice kidneys. Additionally, bone marrow suppressive anemia induced by 5-fluorouracil resulted in enhanced CPA the same as for PHZ mice, but in contrast, anemia with suppression of Epo-production due to nephrotoxicity induced by cisplatin caused a decrease in CPA. These results suggest that CPA in MKE correlates with hematopoietic conditions, and may have a definite role in hematopoiesis through the function of the kidney.
AuthorsT Bamba, I Kashiwakura, M Murakami, M Honda, Y Hayase, Y Takagi
JournalRenal failure (Ren Fail) Vol. 21 Issue 6 Pg. 615-25 (Nov 1999) ISSN: 0886-022X [Print] England
PMID10586424 (Publication Type: Journal Article)
Chemical References
  • Phenylhydrazines
  • phenylhydrazine
  • Erythropoietin
Topics
  • Anemia, Hemolytic (pathology)
  • Animals
  • Erythropoietin (blood)
  • Hematocrit
  • Hematopoiesis
  • Hematopoietic Stem Cells (physiology)
  • Kidney (cytology)
  • Male
  • Mice
  • Phenylhydrazines
  • Spleen (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: